An Open-label Effectiveness Study of a Typhoid Conjugate Vaccine in Kisantu, Democratic Republic of Congo (TyVECO) - Step 2: Typhoid Conjugate Vaccine (TCV) Mass-vaccination Campaign
Latest Information Update: 21 Apr 2023
At a glance
- Drugs Typhoid vaccine Vi conjugate (Primary)
- Indications Typhoid
- Focus Therapeutic Use
- Acronyms TyVECO
- 16 Apr 2023 Status changed from not yet recruiting to recruiting.
- 19 Nov 2021 New trial record